Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 10.79% and Operating profit at -34.52% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 24
3
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
GBP 23 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.59
-999,999.00%
16.59
Revenue and Profits:
Net Sales:
918 Million
(Quarterly Results - Jun 2010)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.81%
0%
-23.81%
6 Months
128.57%
0%
128.57%
1 Year
175.86%
0%
175.86%
2 Years
-30.43%
0%
-30.43%
3 Years
-98.87%
0%
-98.87%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Aptamer Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.79%
EBIT Growth (5y)
-34.52%
EBIT to Interest (avg)
1.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
1,748.92
Tax Ratio
0.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.60
EV to EBIT
0.19
EV to EBITDA
0.10
EV to Capital Employed
12.61
EV to Sales
0.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6559.50%
ROE (Latest)
-15213.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jun'23
Jun'23
Jun'22
Change(%)
Net Sales
1.80
4.00
-55.00%
Operating Profit (PBDIT) excl Other Income
-4.80
-2.10
-128.57%
Interest
0.10
0.00
Exceptional Items
-2.60
-0.10
-2,500.00%
Consolidate Net Profit
-7.80
-2.10
-271.43%
Operating Profit Margin (Excl OI)
-3,172.90%
-624.10%
-254.88%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Aptamer Group Plc 
Aptamer Group Plc
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






